Literature DB >> 31900054

Opioids on Twitter: A Content Analysis of Conversations regarding Prescription Drugs on Social Media and Implications for Message Design.

Parul Jain1, Zulfia Zaher2, Imran Mazid3.   

Abstract

As many as 130 lives are lost every day in the United States due to prescription drug misuse. The opioid crisis is gripping the country and disrupting the lives of millions. Not surprisingly, health organizations are desperately seeking solutions to educate and inform people regarding the issue, often seeking the help of various social media platforms. In this study, we do a content analysis of Twitter messages related to opioids in order to understand the factors that are most likely to influence content sharing. Our findings indicate that structure, source, and the actual content of the post all influence the likelihood of the content's being shared. Specifically, certain types of content enhanced the likelihood of content sharing whereas use of the term "addiction" discouraged retweeting. Theoretical and practical implications for message design are discussed.

Entities:  

Year:  2020        PMID: 31900054     DOI: 10.1080/10810730.2019.1707911

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  4 in total

1.  Social presence for strategic health messages: An examination of state governments' use of Twitter to tackle the Covid-19 pandemic.

Authors:  Imran Mazid
Journal:  Public Relat Rev       Date:  2022-06-23

2.  Identifying features of source and message that influence the retweeting of health information on social media during the COVID-19 pandemic.

Authors:  Jingzhong Xie; Liqun Liu
Journal:  BMC Public Health       Date:  2022-04-22       Impact factor: 4.135

3.  Social Media Mining Toolkit (SMMT).

Authors:  Ramya Tekumalla; Juan M Banda
Journal:  Genomics Inform       Date:  2020-06-15

Review 4.  Twitter usage during global pandemic and corporate reputation in Nigeria.

Authors:  Mary Adelua; Tunji Oyedepo; Odion Odiboh
Journal:  Heliyon       Date:  2021-05-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.